---
layout: page
image:
  feature: DaubEnginePatent.jpg
---
   <head>
      <title>2427-</title>
      <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
</head>
      <li><a href="index.html">Manual of Patent Examining Procedure</a></li>
      <li><a href="mpep-2400.html"><span>Chapter 2400</span></a></li>
      <li><span>Section 2427</span></li>  </ul>
      <div id="yui-main">
         <div class="yui-b">
            <div class="yui-g">  <div xmlns:bf="http://www.uspto.gov/bf" id="article">
               <div>
                  <div xmlns="" class="Section" id="d0e247058">
                     <h1 class="page-title">2427
                        &nbsp;&nbsp;
                        Form Paragraphs and Notice to Comply [R-08.2012]
                     </h1>
                     <div class="Section">
                        <h1 class="page-title" id="d0e247062">2427.01
                           &nbsp;&nbsp;Form Paragraphs  [R-08.2012]
                        </h1>
                        <p id="d0e247066"> See <b><a href="s608.html#d0e50993">MPEP §
                                 608.05</a></b> for form paragraphs which should be used when notifying
                           applicant that a compact disc submitted in accordance with <b><a href="mpep-9020-appx-r.html#d0e318327">37 CFR
                                 1.52(e)</a></b> (i.e., containing a computer program listing, Sequence
                           Listing, and/or table) does not comply with all of the requirements of the
                           <b><a href="mpep-9020-appx-r.html#d0e318327">37
                                 CFR 1.52(e)</a></b>. See also <b><a href="s608.html#d0e50993">MPEP § 608.05(b)</a></b> for
                           form paragraphs which should be used when a table submitted on compact disc does not
                           comply with <b><a href="mpep-9020-appx-r.html#d0e318327">37 CFR 1.52(e)</a></b>. 
                        </p>
                        <p id="d0e247084"> In order to expedite the processing
                           of applications, minor errors pertaining to compliance with the sequence rules may be
                           handled with the first Office action. Examples of minor errors are: when the “Sequence
                           Listing” under <b><a href="mpep-9020-appx-r.html#d0e333653">37 CFR 1.821(c)</a></b> is submitted on
                           compact disc, missing statement in the transmittal letter stating that the two compact
                           discs are identical, missing an incorporation-by-reference of the “Sequence Listing” in
                           the specification, or missing a listing of the files and required information in the
                           transmittal letter; missing statement in the transmittal letter stating that the
                           sequence listing information in computer readable form is identical to the written (on
                           paper or compact disc) “Sequence Listing,” etc. Since the application is ready for
                           examination, the examiner may act on the application and include any objections to the
                           application based on minor errors related to the “Sequence Listing” with his/her Office
                           action. In addition to the form paragraphs reproduced in <b><a href="s608.html#d0e50993">MPEP §
                                 608.05</a></b> and <b><a href="s608.html#d0e50993">§&nbsp;608.05(b)</a></b>, the
                           following form paragraphs are particular to Sequence Listings and should be used as
                           appropriate when notifying applicant of errors in the Sequence Listing: 
                        </p>
                        <div id="d0e247096" class="Example">
                           <p id="d0e247097"> 24.01 - This form paragraph
                              should be used for the first mailing of a Notice to Comply. 
                           </p>
                           <p id="d0e247100"> 24.02 - This form paragraph
                              should be used for the first mailing of a CRF Diskette Problem
                              Report.
                           </p>
                           <p id="d0e247103"> 24.03 - This form paragraph
                              should be used when an applicant has made a <i>bona
                                 fide</i> attempt to comply but the reply generates an error listing from the
                              Scientific and Technical Information Center (STIC). This should be used for a second
                              mailing to applicant unless it is evident that there has been a deliberate omission;
                              this form paragraph may also be used to extend the period for reply for the initially
                              mailed notice.
                           </p>
                           <p id="d0e247109"> 24.04 - This form paragraph
                              should be used when there has been a deliberate omission in the reply or where the
                              reason the reply is incomplete cannot be characterized as an apparent oversight or
                              instance of inadvertence. 
                           </p>
                           <p id="d0e247112"> 24.05 – This form paragraph
                              should be used whenever there is no statement in the transmittal letter that the
                              sequence listing information recorded in computer readable form is identical to the
                              written (on paper or compact disc) sequence listing. 
                           </p>
                           <p id="d0e247115"> 24.05.01 – This form paragraph
                              should be used whenever an amendment is filed with a CRF and there is no statement in
                              the transmittal letter stating that the Sequence Listing information recorded in the
                              CRF is identical to the written sequence listing.
                           </p>
                        </div>
                        <div class="formPara"><a name="fp24.01"></a><h1 class="page-title">¶ 24.01
                              &nbsp;&nbsp;
                              Cover Letter for Use With Notice To Comply With Sequence Rules
                           </h1>
                           <p id="fp-pt-d840e9">This application contains sequence disclosures that are encompassed by the definitions for nucleotide and/or amino acid sequences
                              set forth in <b><a href="mpep-9020-appx-r.html#d0e333653">37 CFR 1.821(a)</a></b>(1) and (a)(2). However, this application fails to comply with the requirements of <b><a href="mpep-9020-appx-r.html#d0e333653">37 CFR 1.821</a></b> through <b><a href="mpep-9020-appx-r.html#d0e334511">1.825 </a></b>for the reason(s) set forth below or on the attached Notice To Comply With Requirements For Patent Applications Containing
                              Nucleotide Sequence And/Or Amino Acid Sequence Disclosures. <b id=""> [1]</b></p>
                           <p id="fp-pt-d840e24">Applicant is given ONE MONTH, or THIRTY DAYS, whichever is longer, from the mailing date of this letter within which to comply
                              with the sequence rules, <b><a href="mpep-9020-appx-r.html#d0e333653">37 CFR 1.821</a></b> - <b><a href="mpep-9020-appx-r.html#d0e334511">1.825</a></b>. Failure to comply with these requirements will result in ABANDONMENT of the application under <b><a href="mpep-9020-appx-r.html#d0e333653">37 CFR 1.821(g)</a></b>. Extensions of time may be obtained by filing a petition accompanied by the extension fee under the provisions of <b><a href="mpep-9020-appx-r.html#d0e323655">37 CFR 1.136(a)</a></b>. In no case may an applicant extend the period for reply beyond the SIX MONTH statutory period. Direct the reply to the undersigned.
                              Applicant is requested to return a copy of the attached Notice to Comply with the reply.
                           </p>
                           <h3>Examiner Note:</h3>  <ul style="list-style-type: none;">
                           <li class="nobull">1. Use this form paragraph <b id="">only for the initial communication to the applicant</b>. Use either form paragraph <b><a href="#fp24.03">24.03</a></b> or <b><a href="#fp24.04">24.04</a></b> for subsequent communications.
                           </li>
                           <li class="nobull">2. In bracket 1, insert how the application fails to comply with the requirements of <b><a href="mpep-9020-appx-r.html#d0e333653">37 CFR 1.821</a></b> through <b><a href="mpep-9020-appx-r.html#d0e334511">1.825</a></b>.
                           </li>
                           <li class="nobull">3. Conclude action with appropriate form paragraph(s) <b><a href="#fp7.100">7.100</a></b>-<b><a href="#fp7.102">7.102</a></b>.
                           </li>
                           <li class="nobull">4. When mailing the Office action, attach a Notice To Comply With Requirements for Patent Applications Containing Nucleotide
                              And/Or Amino Acid Sequence Disclosures, along with a marked-up copy of the Raw Sequence Listing, if any.
                           </li>  </ul>
                        </div>
                        <div class="formPara"><a name="fp24.02"></a><h1 class="page-title">¶ 24.02
                              &nbsp;&nbsp;
                              Cover Letter for Use with CRF Diskette Problem Report
                           </h1>
                           <p id="fp-pt-d842e9">This application contains sequence disclosures that are encompassed by the definitions for nucleotide and/or amino acid sequences
                              set forth in <b><a href="mpep-9020-appx-r.html#d0e333653">37 CFR 1.821(a)</a></b>(1) and (a)(2). A computer readable form (CRF) of the sequence listing was submitted. However, the CRF could not be processed
                              by the Scientific and Technical Information Center (STIC) for the reason(s) set forth on the attached CRF Diskette Problem
                              Report.
                           </p>
                           <p id="fp-pt-d842e15">Applicant is given ONE MONTH, or THIRTY DAYS, whichever is longer, from the mailing date of this letter within which to comply
                              with the sequence rules, <b><a href="mpep-9020-appx-r.html#d0e333653">37 CFR 1.821</a></b> - 1.825. Failure to comply with these requirements will result in ABANDONMENT of the application under <b><a href="mpep-9020-appx-r.html#d0e333653">37 CFR 1.821(g)</a></b>. Extensions of time may be obtained by filing a petition accompanied by the extension fee under the provisions of <b><a href="mpep-9020-appx-r.html#d0e323655">37 CFR 1.136(a)</a></b>. In no case may an applicant extend the period for reply beyond the SIX MONTH statutory period. Direct the reply to the undersigned.
                              Applicant is requested to return a copy of the attached CRF Diskette Problem Report with the reply.
                           </p>
                           <h3>Examiner Note:</h3>  <ul style="list-style-type: none;">
                           <li class="nobull">1. Use this form paragraph <b id="">only for the initial communication to the applicant</b>. Use either form paragraph <b><a href="#fp24.03">24.03</a></b> or <b><a href="#fp24.04">24.04</a></b> for subsequent communications.
                           </li>
                           <li class="nobull">2. Conclude action with appropriate form paragraph(s) <b><a href="#fp7.100">7.100</a></b>-<b><a href="#fp7.102">7.102</a></b>.
                           </li>
                           <li class="nobull">3. When mailing the Office action, attach the CRF Diskette Problem Report.</li>  </ul>
                        </div>
                        <div class="formPara"><a name="fp24.03"></a><h1 class="page-title">¶ 24.03
                              &nbsp;&nbsp;
                              Compact Disc/CRF Submission Is Not Fully Responsive, Bona Fide Attempt
                           </h1>
                           <p id="fp-pt-d844e9">The reply filed <b id="">[1]</b> is not fully responsive to the Office communication mailed <b id="">[2]</b> for the reason(s) set forth below or on the attached Notice To Comply With The Sequence Rules or CRF Diskette Problem Report.
                           </p>
                           <p id="fp-pt-d844e18">Since the above-mentioned reply appears to be <i>bona fide</i>, applicant is given a TIME PERIOD of <b id="">ONE (1) MONTH</b> or <b id="">THIRTY (30) DAYS</b> from the mailing date of this notice, whichever is longer, within which to supply the omission or correction in order to
                              avoid abandonment. EXTENSIONS OF THIS TIME PERIOD MAY BE GRANTED UNDER <b><a href="mpep-9020-appx-r.html#d0e323655">37 CFR 1.136(a)</a></b>.
                           </p>
                           <h3>Examiner Note:</h3>  <ul style="list-style-type: none;">
                           <li class="nobull">1. This form paragraph may be used whether or not the six-month period for reply has expired. It is intended for use whenever
                              a <b id="">bona fide</b> reply has been submitted. This practice does not apply where there has been a deliberate omission of some necessary part
                              of a complete reply or where the reason the reply is incomplete cannot be characterized as an apparent oversight or apparent
                              inadvertence. Under such cases the examiner has no authority to grant an extension if the six-month period for reply has expired.
                              Use form paragraph <b><a href="#fp24.04">24.04</a></b> under such circumstances.
                           </li>
                           <li class="nobull">2. In bracket 1, insert the date of the reply and in bracket 2, insert the mail date of the communication requiring compliance.</li>
                           <li class="nobull">3. When mailing the Office action, attach a Notice To Comply With Requirements For Patent Applications Containing Nucleotide
                              Sequence And/Or Amino Acid Sequence Disclosures, if any, along with a marked-up copy of the Raw Sequence Listing, or CRF Diskette
                              Problem Report.
                           </li>
                           <li class="nobull">4. See <b><a href="mpep-9020-appx-r.html#d0e323620">37 CFR 1.135(c)</a></b>, 1.821(g); <b><a href="s710.html#d0e79923">MPEP §§ 710.02(c)</a></b>, <b><a href="s711.html#d0e81694">711.02(a)</a></b>, <b><a href="s714.html#d0e86906">714.02</a></b> and <b><a href="s714.html#d0e87038">714.03</a></b>.
                           </li>  </ul>
                        </div>
                        <div class="formPara"><a name="fp24.04"></a><h1 class="page-title">¶ 24.04
                              &nbsp;&nbsp;
                              Compact Disc/CRF Submission Is Not Fully Responsive
                           </h1>
                           <p id="fp-pt-d846e9">The communication filed <b id="">[1]</b> is not fully responsive to the communication mailed <b id="">[2]</b> for the reason(s) set forth below or on the attached Notice To Comply With The Sequence Rules or CRF Diskette Problem Report.
                           </p>
                           <p id="fp-pt-d846e18">If a complete reply has not been submitted by the time the shortened statutory period set in the communication mailed <b id="">[3]</b> has expired, this application will become abandoned unless applicant corrects the deficiency and obtains an extension of
                              time under <b><a href="mpep-9020-appx-r.html#d0e323655">37 CFR 1.136(a)</a></b>. In no case may an applicant extend the period for reply beyond the SIX MONTH statutory period.
                           </p>
                           <h3>Examiner Note:</h3>  <ul style="list-style-type: none;">
                           <li class="nobull">1. This form paragraph may not be used when the six month period for reply has expired. Use this form paragraph in the situation
                              where, in the reply (within the six-months), there has been a deliberate omission of some necessary part of a complete reply.
                              When the reply appears to be bona fide, but through an apparent oversight or inadvertence failed to provide a complete reply,
                              use form paragraph <b><a href="#fp24.03">24.03</a></b>.
                           </li>
                           <li class="nobull">2. In bracket 1, insert the date of the reply and in brackets 2 and 3, insert the mail date of the communication requiring compliance.</li>
                           <li class="nobull">3. When mailing the Office action, attach a Notice To Comply With Requirements For Patent Applications Containing Nucleotide
                              Sequence And/Or Amino Acid Sequence Disclosures, if any, along with a marked-up copy of the Raw Sequence Listing, or CRF Diskette
                              Problem Report.
                           </li>  </ul>
                        </div>
                        <div class="formPara"><a name="fp24.05"></a><h1 class="page-title">¶ 24.05
                              &nbsp;&nbsp;
                              CD-ROM/CD-R Requirements (Missing Sequence Listing/CRF Statement)
                           </h1>
                           <p id="fp-pt-d847e9">This application is objected to because it does not include the statement “the sequence listing information recorded in computer
                              readable form is identical to the written (on paper or compact disc) sequence listing” and, where applicable, includes no
                              new matter, as required by 37 CFR <b><a href="mpep-9020-appx-r.html#d0e333653">1.821(e)</a></b>, <b><a href="mpep-9020-appx-r.html#d0e333653">1.821(f)</a></b>, <b><a href="mpep-9020-appx-r.html#d0e333653">1.821(g)</a></b>, <b><a href="mpep-9020-appx-r.html#d0e334511">1.825(b)</a></b> or <b><a href="mpep-9020-appx-r.html#d0e334511">1.825(d)</a></b>. Correction is required.
                           </p>
                           <h3>Examiner Note:</h3>
                           <p id="fp-pt-d847e29">Use this form paragraph when there is no statement in the transmittal letter stating that the sequence listing information
                              recorded in the CRF is identical to the written sequence listing
                           </p>
                        </div>
                        <div class="formPara"><a name="fp24.05.01"></a><h1 class="page-title">¶ 24.05.01
                              &nbsp;&nbsp;
                              CD-ROM/CD-R Requirements (Missing Sequence Listing/CRF Statement in an Amendment Filed with a CRF)
                           </h1>
                           <p id="fp-pt-d848e9">The amendment filed <b id="">[1]</b> is objected to because it does not include the statement “the sequence listing information recorded in computer readable
                              form is identical to the written (on paper or compact disc) sequence listing” and, where applicable, a statement that the
                              submission includes no new matter, as required by 37 CFR <b><a href="mpep-9020-appx-r.html#d0e333653">1.821(e)</a></b>, <b><a href="mpep-9020-appx-r.html#d0e333653">1.821(f)</a></b>, <b><a href="mpep-9020-appx-r.html#d0e333653">1.821(g)</a></b>, <b><a href="mpep-9020-appx-r.html#d0e334511">1.825(b)</a></b> or <b><a href="mpep-9020-appx-r.html#d0e334511">1.825(d)</a></b>. A statement that the sequence listing information is identical is required.
                           </p>
                           <h3>Examiner Note:</h3>  <ul style="list-style-type: none;">
                           <li class="nobull">1. Use this form paragraph when there is no statement in the transmittal letter stating that the sequence listing information
                              recorded in the CRF is identical to the written sequence listing.
                           </li>
                           <li class="nobull">2. In bracket 1, insert the date of the amendment.</li>  </ul>
                        </div>
                     </div>
                     <div class="Section">
                        <h1 class="page-title" id="d0e247506">2427.02
                           &nbsp;&nbsp;Notice To Comply  [R-08.2012]
                        </h1>
                        <p id="d0e247510">The text of the Notice to Comply
                           With Requirements For Patent Applications Containing Nucleotide Sequence and for Amino
                           Acid Sequence Disclosures, Form PTO-1661, follows. The appropriate box on the notice
                           should be checked depending upon the particular deficiencies that have been identified.
                           In the alternative, a letter may be written notifying applicant of any deficiencies that
                           have been identified. A copy of the “Raw Sequence Listing,” where available, should also
                           be sent to the applicant. The “Raw Sequence Listing” should also be entered into the
                           application file upon receipt from STIC. 
                        </p>
                        <div class="figure" id="d0e247513">Form PTO-1661. Notice to Comply with Requirements for Patent
                           Applications Containing Nucleotide Sequence and/or Amino Acid Sequence
                           Disclosures<img src="graphics/2427_02.png" alt="Notice to Comply with Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures. (Form PTO-1661)" width="733" height="935"></div>
                     </div>
                     <p align="right"><a href="#top">[top]</a></p>
                  </div>
               </div>
               <div>
                  <h1 class="page-title">&nbsp;</h1>
               </div>  </div>
            </div>
         </div>
      </div>
      <div class="yui-b">
         <div id="aside">  <div id="rdms-sub-nav-container" xmlns:bf="http://www.uspto.gov/bf">
            <ul id="sub-nav">
               <li xmlns=""><a href="s2401.html">2401-Introduction</a></li>
               <li xmlns=""><a href="s2402.html">2402-The Deposit Rules</a></li>
               <li xmlns=""><a href="s2403.html">2403-Deposit of Biological Material</a><ul>
                     <li><a href="s2403.html#d0e240728">2403.01-Material Capable of Self- Replication</a></li>
                     <li><a href="s2403.html#d0e240735">2403.02-Plant Material</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2404.html">2404-Need or Opportunity to Make a Deposit</a><ul>
                     <li><a href="s2404.html#d0e240816">2404.01-Biological Material That Is Known and Readily Available to the Public</a></li>
                     <li><a href="s2404.html#d0e240930">2404.02-Biological Material That Can Be Made or Isolated Without Undue Experimentation</a></li>
                     <li><a href="s2404.html#d0e240946">2404.03-Reference to a Deposit in the Specification</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2405.html">2405-Acceptable Depository</a></li>
               <li xmlns=""><a href="s2406.html">2406-Time of Making an Original Deposit</a><ul>
                     <li><a href="s2406.html#d0e241742">2406.01-Description in Application Specification</a></li>
                     <li><a href="s2406.html#d0e241769">2406.02-Deposit After Filing Date - Corroboration</a></li>
                     <li><a href="s2406.html#d0e241779">2406.03-Possible Loss of U.S. Filing Date in Other Countries</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2407.html">2407-Replacement or Supplement of Deposit</a><ul>
                     <li><a href="s2407.html#d0e241898">2407.01-In a Pending Application</a></li>
                     <li><a href="s2407.html#d0e241922">2407.02-After a Patent Has Issued</a></li>
                     <li><a href="s2407.html#d0e241949">2407.03-Failure to Replace</a></li>
                     <li><a href="s2407.html#d0e241964">2407.04-Treatment of Replacement</a></li>
                     <li><a href="s2407.html#d0e241982">2407.05-Exemption From Replacement</a></li>
                     <li><a href="s2407.html#d0e241992">2407.06-Replacement May Not Be Recognized</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2408.html">2408-Term of Deposit</a></li>
               <li xmlns=""><a href="s2409.html">2409-Viability of Deposit</a></li>
               <li xmlns=""><a href="s2410.html">2410-Furnishing of Samples</a><ul>
                     <li><a href="s2410.html#d0e242157">2410.01-Conditions of Deposit</a></li>
                     <li><a href="s2410.html#d0e242206">2410.02-Certification of Statement of Availability of Deposit</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2411.html">2411-Examination Procedures</a><ul>
                     <li><a href="s2411.html#d0e242312">2411.01-Rejections Based on Deposit Issue</a></li>
                     <li><a href="s2411.html#d0e242401">2411.02-Replies to Rejections Based on Deposit Issue</a></li>
                     <li><a href="s2411.html#d0e242424">2411.03-Application in Condition for Allowance Except for Deposit</a></li>
                     <li><a href="s2411.html#d0e242459">2411.04-After a Patent Has Been Granted</a></li>
                     <li><a href="s2411.html#d0e242505">2411.05-Content of Application with Respect to Deposited Material</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2412-2419.html">2412-2419-[Reserved]</a></li>
               <li xmlns=""><a href="s2420.html">2420-The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures - the Sequence
                     Rules</a></li>
               <li xmlns=""><a href="s2421.html">2421-Overview of the Sequence Rules</a><ul>
                     <li><a href="s2421.html#d0e242552">2421.01-Applications Affected</a></li>
                     <li><a href="s2421.html#d0e242568">2421.02-Summary of the Requirements of the Sequence Rules</a></li>
                     <li><a href="s2421.html#d0e242594">2421.03-Notification of a Failure to Comply</a></li>
                     <li><a href="s2421.html#d0e242622">2421.04-Future Changes to the Sequence Rules</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2422.html">2422-Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications</a><ul>
                     <li><a href="s2422.html#d0e245121">2422.01-Definitions of Nucleotide and/or Amino Acids for Purpose of Sequence Rules</a></li>
                     <li><a href="s2422.html#d0e245175">2422.02-The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures</a></li>
                     <li><a href="s2422.html#d0e245191">2422.03-The Requirements for a Sequence Listing and Sequence Identifiers; Sequences Embedded in Application Text; Variants of a Presented
                           Sequence</a></li>
                     <li><a href="s2422.html#d0e245299">2422.04-The Requirement for a Computer Readable Copy of the Official Copy of the Sequence Listing</a></li>
                     <li><a href="s2422.html#d0e245330">2422.05-Reference to Previously Filed Identical Computer Readable Form; Continuing or Derivative Applications; Request for Transfer
                           of Computer Readable Form</a></li>
                     <li><a href="s2422.html#d0e245358">2422.06-Requirement for Statement Regarding Content of Official and Computer Readable Copies of Sequence Listing</a></li>
                     <li><a href="s2422.html#d0e245376">2422.07-Requirements for Compliance, Statements Regarding New Matter, and Sanctions for Failure to Comply</a></li>
                     <li><a href="s2422.html#d0e245454">2422.08-Presumptions Regarding Compliance</a></li>
                     <li><a href="s2422.html#d0e245470">2422.09-Box Sequence; Hand Delivery of Sequence Listings and Computer Readable Forms</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2423.html">2423-Symbols and Format To Be Used for Nucleotide and/or Amino Acid Sequence Data</a><ul>
                     <li><a href="s2423.html#d0e245579">2423.01-Format and Symbols To Be Used in Sequence Listings</a></li>
                     <li><a href="s2423.html#d0e245618">2423.02-Depiction of Coding Regions</a></li>
                     <li><a href="s2423.html#d0e245637">2423.03-Presentation and Enumeration of Sequences</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2424.html">2424-Requirements for Nucleotide and/or Amino Acid Sequences as Part of the Application Papers</a><ul>
                     <li><a href="s2424.html#d0e246252">2424.01-Informational Requirements for the Sequence Listing</a></li>
                     <li><a href="s2424.html#d0e246289">2424.02-Sequence Listing Numeric Identifiers</a></li>
                     <li><a href="s2424.html#d0e246838">2424.03-Additional Miscellaneous Requirements</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2425.html">2425-Form and Format for Nucleotide and/or Amino Acid Sequence Submissions in Computer Readable Form</a></li>
               <li xmlns=""><a href="s2426.html">2426-Amendments to or Replacement of Sequence Listing and Computer Readable Copy Thereof</a></li>
               <li xmlns=""><a href="s2427.html">2427-Form Paragraphs and Notice to Comply</a><ul>
                     <li><a href="s2427.html#d0e247062">2427.01-Form Paragraphs</a></li>
                     <li><a href="s2427.html#d0e247506">2427.02-Notice To Comply</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2428.html">2428-Sample Statements</a></li>
               <li xmlns=""><a href="s2429.html">2429-Helpful Hints for Compliance</a></li>
               <li xmlns=""><a href="s2430.html">2430-PatentIn Information; Utilities Programs; Training</a></li>
               <li xmlns=""><a href="s2431.html">2431-Sample Sequence Listing</a></li>
               <li xmlns=""><a href="s2432-2433.html">2432-2433-[Reserved]</a></li>
               <li xmlns=""><a href="s2434.html">2434-Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences</a></li>
               <li xmlns=""><a href="s2435.html">2435-Publishing of Patents and Patent Application Publications with Lengthy Sequence Listings</a></li>
            </ul>  </div>
         </div>
      </div>  </div>
      

  <div style="text-align:right"> Last Modified: 

     

    03/27/2014 10:10:34 

  </div>

</div>

</div>




<!-- End of footer2.html -->


   </body>
</html>